U Svensson

733 total citations
20 papers, 592 citations indexed

About

U Svensson is a scholar working on Organic Chemistry, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, U Svensson has authored 20 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Pharmacology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in U Svensson's work include Drug-Induced Hepatotoxicity and Protection (5 papers), Malaria Research and Control (5 papers) and Computational Drug Discovery Methods (3 papers). U Svensson is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (5 papers), Malaria Research and Control (5 papers) and Computational Drug Discovery Methods (3 papers). U Svensson collaborates with scholars based in Sweden, Denmark and Vietnam. U Svensson's co-authors include Michael Ashton, Jonas Nilsson, Uli Hacksell, Domènec J. Sánchez, Per Lindberg, Arvid Carlsson, L. -E. Arvidsson, Stephan Hjorth, Håkan Wikström and J. L. Tedesco and has published in prestigious journals such as FEBS Letters, Cellular and Molecular Life Sciences and Molecular Pharmacology.

In The Last Decade

U Svensson

20 papers receiving 565 citations

Peers

U Svensson

CMN

PHARM

PHEOH

CTM

Mithat Gunduz United States

Albert A. Manian United States

Nilanjan Saha India

W. Perry Gordon United States

Ian T. Crosby Australia

Patricia A. Maguire United States

Gilda Neves Brazil

Shridhar V. Andurkar United States

Gopinadh Bhyrapuneni India

F. Giménez France

Mithat Gunduz United States

U Svensson

192 ×0.7

157 ×0.6

CMN

159 ×1.0

PHARM

44 ×0.4

PHEOH

75 ×0.9

CTM

Citations per year, relative to U Svensson U Svensson (= 1×) peers Mithat Gunduz

Countries citing papers authored by U Svensson

Since Specialization

Citations

This map shows the geographic impact of U Svensson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U Svensson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U Svensson more than expected).

Fields of papers citing papers by U Svensson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U Svensson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U Svensson. The network helps show where U Svensson may publish in the future.

Co-authorship network of co-authors of U Svensson

This figure shows the co-authorship network connecting the top 25 collaborators of U Svensson. A scholar is included among the top collaborators of U Svensson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U Svensson. U Svensson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Svensson, U, et al.. (2003). Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto‐induction in the rat by use of nonlinear mixed effects modelling. Biopharmaceutics & Drug Disposition. 24(2). 71–85. 19 indexed citations

Svensson, U, Thomas Senderovitz, & Mats O. Karlsson. (2003). Population PK/PD Modeling of Testosterone (T), LH and Dihydrotestosterone (DHT) Response to Single SC Degarelix in Male Volunteers. Clinical Pharmacology & Therapeutics. 73(2). 3 indexed citations

Svensson, U, Mohamed Hassan Alin, Mats O. Karlsson, Yngve Bergqvist, & Michael Ashton. (2002). Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. European Journal of Clinical Pharmacology. 58(5). 339–351. 42 indexed citations

Gupta, Shilpi, U Svensson, & Michael Ashton. (2001). In vitro evidence for auto-induction of artemisinin metabolism in the rat. European Journal of Drug Metabolism and Pharmacokinetics. 26(3). 173–178. 16 indexed citations

Mihara, Kazuo, U Svensson, Gunnel Tybring, et al.. (1999). Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19. Fundamental and Clinical Pharmacology. 13(6). 671–675. 24 indexed citations

Svensson, U, Rikard Sandström, Örjan Carlborg, Hans Lennernäs, & Michael Ashton. (1999). High In Situ Rat Intestinal Permeability of Artemisinin Unaffected by Multiple Dosing and with No Evidence of P-glycoprotein Involvement. Drug Metabolism and Disposition. 27(2). 227–232. 53 indexed citations

Svensson, U, Michael Ashton, Trinh Ngoc Hai, et al.. (1998). Artemisinin induces omeprazole metabolism in human beings*. Clinical Pharmacology & Therapeutics. 64(2). 160–167. 68 indexed citations

Sjödin, Lars & U Svensson. (1990). Vasodepressor activity of pharmaceutical formulations of heparin.. PubMed. 2(2). 89–100. 1 indexed citations

Seeman, Philip, Masayuki Watanabe, Dimitri E. Grigoriadis, et al.. (1985). Dopamine D2 receptor binding sites for agonists. A tetrahedral model.. Molecular Pharmacology. 28(5). 391–399. 116 indexed citations

10.

Hjorth, Stephan, Arvid Carlsson, Håkan Wikström, et al.. (1981). 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sciences. 28(11). 1225–1238. 194 indexed citations

11.

Hacksell, Uli, U Svensson, Jonas Nilsson, et al.. (1980). ChemInform Abstract: N‐ALKYLATED 2‐AMINOTETRALINS: CENTRAL DOPAMINE‐RECEPTOR STIMULATING ACTIVITY. Chemischer Informationsdienst. 11(15). 21 indexed citations

12.

WIKSTROEM, H., Per Lindberg, Stephan Hjorth, et al.. (1979). ChemInform Abstract: PIVALOYL ESTERS OF N,N‐DIALKYLATED DOPAMINE CONGENERS. CENTRAL DOPAMINE‐RECEPTOR STIMULATING ACTIVITY. Chemischer Informationsdienst. 10(8). 1 indexed citations

13.

Resul, Bahram, Björn Ringdahl, Uli Hacksell, U Svensson, & Richard Dahlbom. (1979). Acetylene compounds of potential pharmacological value. XXXI. Studies on N-(4-tert-amino-2-butynyl) carboxamides as muscarinic agonists.. PubMed. 16(4). 225–32. 4 indexed citations

14.

Svensson, U, Uli Hacksell, & Richard Dahlbom. (1978). Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(1). 67–70. 4 indexed citations

15.

Svensson, U & Richard Dahlbom. (1975). Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.. PubMed. 12(3). 209–14. 3 indexed citations

16.

Dahlbom, Richard, et al.. (1974). Stereospecificity of oxotremorine antagonists. Cellular and Molecular Life Sciences. 30(10). 1165–1167. 5 indexed citations

17.

Bogentoft, Conny, U Svensson, & B Karlén. (1973). Mass spectrometry of acetylenic amines. 3. The fragmentation of some tertiary and secondary propargylic amines.. PubMed. 10(3). 215–22. 2 indexed citations

18.

Svensson, U, et al.. (1973). Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.. PubMed. 10(6). 435–40. 3 indexed citations

19.

Lindgren, J.‐E., Stig Agurell, Jan O. Lundström, & U Svensson. (1971). Detection of biochemical intermediates by mass fragmentography: Mescaline and tetrahydroisoquinoline precursors. FEBS Letters. 13(1). 21–27. 6 indexed citations

20.

Svensson, U, et al.. (1970). N-(t-Aminoalkynyl)-substituted pyrrolidones as oxotremorine antagonists. Cellular and Molecular Life Sciences. 26(11). 1232–1233. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact